OpenURL Connection Search

Select item for more details and to access through your institution.

Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.
Published in:
Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 1, p. 69, doi. 10.17219/acem/162969
By:
- Zagórowicz, Edyta;
- Cichoż-Lach, Halina;
- Kopertowska-Majchrzak, Maria;
- Eder, Piotr;
- Stawczyk-Eder, Kamila;
- Talar-Wojnarowska, Renata;
- Zatorski, Hubert;
- Solarska-Półchłopek, Anna;
- Filip, Rafał;
- Janiak, Maria;
- Skrobot, Krzysztof;
- Kłopocka, Maria;
- Liebert, Ariel;
- Kaczka, Aleksandra;
- Wojciechowski, Krzysztof;
- Drygała, Szymon;
- Michalak, Agata
Publication type:
Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Published in:
Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231151295
By:
- Eder, Piotr;
- Kłopocka, Maria;
- Cichoż-Lach, Halina;
- Talar-Wojnarowska, Renata;
- Kopertowska-Majchrzak, Maria;
- Michalak, Agata;
- Filip, Rafał;
- Waszak, Katarzyna;
- Stawczyk-Eder, Kamila;
- Janiak, Maria;
- Skrobot, Krzysztof;
- Liebert, Ariel;
- Zatorski, Hubert;
- Solarska-Półchłopek, Anna;
- Krogulecki, Michał;
- Pękała, Anna;
- Poniewierka, Elżbieta;
- Smoła, Izabela;
- Kaczka, Aleksandra;
- Wojciechowski, Krzysztof
Publication type:
Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Published in:
Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231151295
By:
- Eder, Piotr;
- Kłopocka, Maria;
- Cichoż-Lach, Halina;
- Talar-Wojnarowska, Renata;
- Kopertowska-Majchrzak, Maria;
- Michalak, Agata;
- Filip, Rafał;
- Waszak, Katarzyna;
- Stawczyk-Eder, Kamila;
- Janiak, Maria;
- Skrobot, Krzysztof;
- Liebert, Ariel;
- Zatorski, Hubert;
- Solarska-Półchłopek, Anna;
- Krogulecki, Michał;
- Pękała, Anna;
- Poniewierka, Elżbieta;
- Smoła, Izabela;
- Kaczka, Aleksandra;
- Wojciechowski, Krzysztof
Publication type:
Article
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
Published in:
Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211036456
By:
- Cichoż-Lach, Halina;
- Michalak, Agata;
- Kopertowska-Majchrzak, Maria;
- Eder, Piotr;
- Stawczyk-Eder, Kamila;
- Waszak, Katarzyna;
- Talar-Wojnarowska, Renata;
- Zatorski, Hubert;
- Solarska-Półchłopek, Anna;
- Chmielnicki, Jarosław;
- Filip, Rafał;
- Pękala, Anna;
- Janiak, Maria;
- Skrobot, Krzysztof;
- Kasińska, Ewa;
- Krogulecki, Michał;
- Królikowski, Piotr;
- Kłopocka, Maria;
- Liebert, Ariel;
- Poniewierka, Elżbieta
Publication type:
Article

Found: 4

Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.

Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.

Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.

Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).